Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Top genes
New
Contact us
^
Login
BIOMARKER:
BCL2 rearrangement
i
Other names:
BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
596
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
Heatmap
News
Twitter
Trials
Reset Filters
Veri cancer hierarchy
x
x
x
x
BCL2 rearrangement
Diffuse Large B Cell Lymphoma
BCL2 rearrangement
Diffuse Large B Cell Lymphoma
rituximab
Sensitive: C2 – Inclusion Criteria
rituximab
Sensitive
:
C2
rituximab
Sensitive: C2 – Inclusion Criteria
rituximab
Sensitive
:
C2
BCL2 rearrangement
Lymphoma
BCL2 rearrangement
Lymphoma
CAR-T immunotherapy
Resistant: C3 – Early Trials
CAR-T immunotherapy
Resistant
:
C3
CAR-T immunotherapy
Resistant: C3 – Early Trials
CAR-T immunotherapy
Resistant
:
C3
BCL2 rearrangement
Diffuse Large B Cell Lymphoma
BCL2 rearrangement
Diffuse Large B Cell Lymphoma
EPOCH-R
Sensitive: C3 – Early Trials
EPOCH-R
Sensitive
:
C3
EPOCH-R
Sensitive: C3 – Early Trials
EPOCH-R
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
